| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-732
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-545
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-715
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-716
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39558
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-07
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-899
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-716
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
| filingDate |
2003-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2006-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2006502167-A |
| titleOfInvention |
Cancer treatment using whole glucan particles and antibodies |
| abstract |
The present invention relates to methods using whole glucan particles and complement activating antibodies for anti-tumor therapy. Whole glucan particles enhance the tumoricidal activity of the innate immune system by binding to the C3 complement protein receptor CR3. This binding enhances innate immune system cytotoxicity and stimulates the release of activated cytokines. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8637045-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008503472-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2021169495-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017524737-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2021049587-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9682135-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7311560-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2021020921-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8580275-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017507152-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017501399-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019203004-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008023425-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7088502-B2 |
| priorityDate |
2002-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |